Wegovy® · Semaglutide
Your solution for weight loss
A once-weekly GLP-1 injection that works with your appetite signals — prescribed and monitored by licensed clinicians through secure telehealth.
HIPAA CompliantLicensed PhysiciansFDA-Approved RxTelehealth Care
The Ongo difference
Physician-guided care, built around you
Weight loss support
GLP-1 therapy that works with your natural appetite signals for gradual, sustainable progress.
Medical guidance
Every patient is evaluated by a licensed clinician before any prescription is considered.
Personalized plans
Dosing schedules tailored to your tolerance, goals, and clinician recommendations.
Ongoing coaching
Care Team support from evaluation through delivery and beyond.
About Wegovy
What is Wegovy?
Wegovy is a prescription GLP-1 medication containing semaglutide, FDA-approved for chronic weight management. It mimics a natural hormone that helps regulate appetite and food intake — supporting gradual, medically supervised weight loss when combined with lifestyle changes and ongoing clinician oversight.
See if you qualify →How it works
How does Wegovy work?
Wegovy activates GLP-1 receptors to slow gastric emptying, reduce appetite signals, and help you feel fuller sooner. It is not a stimulant — it works with your biology under clinician supervision.
Get Started Now →Your journey
Our step-by-step process
Complete your free online evaluation
Share your health history, goals, and BMI through our secure intake — takes about 5 minutes.
Meet with a licensed clinician
A board-certified provider reviews your case via telehealth and determines if Wegovy is appropriate.
Receive your personalized plan
If prescribed, your clinician creates a titration schedule tailored to your tolerance and progress.
Medication delivered to your door
Your prescription ships discreetly from a licensed U.S. pharmacy with ongoing Care Team support.
Is Wegovy right for you?
- Adults with obesity (BMI ≥ 30)
- Adults overweight (BMI ≥ 27) with a weight-related condition
- Committed to nutrition and activity changes alongside medication
- No contraindications identified by your clinician
Safety
Important safety information
Common side effects
Nausea, diarrhea, constipation, and vomiting may occur — especially during dose increases. Most improve over time.
Serious risks
Wegovy may cause thyroid tumors in rodents. It is not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Do not use if
You are pregnant, breastfeeding, or have a history of severe allergic reactions to semaglutide or any Wegovy ingredient.
Talk to your doctor
Share your full medication list and medical history. Your Ongo clinician will review risks and benefits before prescribing.
Clinical trial results
| Measure | Wegovy | Placebo |
|---|---|---|
| Avg. weight change (68 weeks) | −15.0% | −2.4% |
| Patients losing ≥5% body weight | 83.5% | 31.1% |
| Patients losing ≥10% body weight | 66.1% | 11.8% |
*Based on STEP 1 trial data. Individual results vary. Prescription required.
Watch our Wegovy overview
How to inject Wegovy
- Wash hands and choose your injection site.
- Attach a new needle and check the pen flow if needed.
- Pinch skin, insert needle, and press until dose is delivered.
- Dispose of the needle safely and store the pen refrigerated.
Rotate injection sites each week. Your clinician will walk you through your first dose during your visit.
AbdomenFront of thighUpper arm
Dosage & administration
Wegovy is titrated gradually to reduce side effects. Your Ongo clinician personalizes this schedule based on your response.
- Weeks 1–4: 0.25 mg once weekly (starting dose)
- Weeks 5–8: 0.5 mg once weekly
- Weeks 9–12: 1 mg once weekly
- Weeks 13–16: 1.7 mg once weekly
- Week 17+: 2.4 mg once weekly (maintenance)
Social proof
Patient testimonials
Real stories from patients on physician-guided Wegovy care.
The appetite changes were noticeable within the first few weeks. Having a real doctor guide the dosing made me feel safe the whole way.
Sarah M.
Ongo patient · on Wegovy
I appreciated that nobody rushed me. The evaluation was thorough, and my care team answered every question before I started.
James T.
4,000+Patients trust Ongo
Meet our medical team
Dr. Miller
Licensed Physician
Physician-guided weight loss and metabolic health consultations.
Dr. Niles
Board-Certified Physician
30+ years of clinical experience in patient-centered obesity care.
Dr. Krasne
Licensed Physician
Board-certified clinician focused on individualized treatment planning.
Dr. Bugailiskis
Board-Certified Physician
Evaluates patients based on health history, goals, and clinical needs.
Wegovy is FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity.
Both contain semaglutide. Wegovy is FDA-approved for chronic weight management at doses up to 2.4 mg weekly. Ozempic is approved for type 2 diabetes. Your clinician determines which is appropriate.
Many patients notice appetite changes within weeks. Meaningful weight loss typically builds over months as dosing is titrated. Individual results vary.
Coverage varies by plan. Your Ongo care team can help you understand options. Brand-name and compounded alternatives may differ in cost.
Yes — if clinically appropriate. Every patient completes a licensed clinician evaluation before any prescription is considered.
Ready to see if Wegovy is right for you?
Take a free evaluation. A licensed clinician will review your history and recommend a plan — only prescribing when clinically appropriate.
Get Started →Wegovy® is a registered trademark of Novo Nordisk. This page is for educational purposes and does not constitute medical advice. Side effects may occur. Prescriptions are issued only when medically appropriate. Individual results vary.